Amgen makes regenerative medicine play, backing $25M Fortuna round to move neural stem cells into the clinic – FierceBiotech
|
Amgen makes regenerative medicine play, backing $25M Fortuna round to move neural stem cells into the clinic
FierceBiotech Amgen’s VC wing has invested in Fortuna Fix to help move autologous neural stem cells into the clinic. The $25 million series B sets regenerative medicine startup Fortuna up to move candidates against Parkinson’s disease and spinal cord injury into the … |
|
NPL and Imperial College London Launch a New Virtual Lab to Establish the UK Centre for Engineering Biology …
PR Newswire UK (press release) The virtual lab is a new collaboration between institutes undertaking world-leading research in biological measurements, which positions UK as a global leader in the industrialisation of synthetic biology: NPL, LGC, the UK’s National Measurement … |
|
Even if This ALS Stem Cell Experiment Fails, It’ll Be Considered a Success
Daily Beast “I think it’s a very exciting potential to explore, to see if excitability of nerve cells is one of the reasons causing the disease and therefore this drug might dampen that,” she said. “We can ask questions of those [stem cell] lines and use them for … |